Phase i randomized dose-ascending placebo-controlled trials of ferroquine - A candidate anti-malarial drug - In adults with asymptomatic Plasmodium falciparum infection

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Mombo Ngoma, Ghyslain ^a,b,c   Supan, Christian ^a,b   Dal Bianco, Matthias P ^a,b   Missinou, Michel A ^a,b   Matsiegui, Pierre Blaise ^a,b   Ospina Salazar, Carmen L ^a,b   Issifou, Saadou ^a,b   Ter Minassian, Daniel ^d   Ramharter, Michael ^a,e   Kombila, Maryvonne ^c   Kremsner, Peter G ^a,b   Lell, Bertrand ^a,b  

^a ALBERT SCHWEITZER HOSPITAL   (Gabon)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITÉ DES SCIENCES DE LA SANTÉ   (Gabon)

^d SANOFI   (France)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FERROQUINE; PLACEBO; AMINOQUINOLINE DERIVATIVE; ANTIMALARIAL AGENT; FERROUS ION;

ABDOMINAL PAIN; ADULT; ARTHRALGIA; ARTICLE; BACKACHE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NAUSEA; PHASE 1 CLINICAL TRIAL; PLASMODIUM FALCIPARUM; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; T WAVE; TOOTH PAIN; TREATMENT OUTCOME; VOMITING; ADOLESCENT; ASYMPTOMATIC DISEASE; CLINICAL TRIAL; ISOLATION AND PURIFICATION; MIDDLE AGED;

ADOLESCENT; ADULT; AMINOQUINOLINES; ANTIMALARIALS; ASYMPTOMATIC DISEASES; DOUBLE-BLIND METHOD; FERROUS COMPOUNDS; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PLACEBOS; PLASMODIUM FALCIPARUM; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952080374     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-53     Document Type: Article

References (32)

1. Evidence of artemisinin-resistant malaria in western Cambodia. H Noedl Y Se K Schaecher BL Smith D Socheat MM Fukuda, N Engl J Med 2008 359 2619 10.1056/NEJMc0805011 19064625
2. Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue. C Biot G Glorian LA Maciejewski JS Brocard O Domarle G Blampain P Millet AJ Georges H Abessolo D Dive J Lebibi, J Med Chem 1997 40 3715 3718 10.1021/jm970401y 9371235 (Pubitemid 27481715)
3. Synthesis and antimalarial activity in vitro of potential metabolites of ferrochloroquine and related compounds. C Biot L Delhas CM N'Diaye LA Maciejewski D Camus D Dive JS Brocard D Dive, Bioorg Med Chem 1999 7 2844 10.1016/S0968-0896(99)00224-2 (Pubitemid 30105856)
4. In vitro and in vivo antimalarial activity of ferrochloroquine, a ferrocenyl analogue of chloroquine against chloroquine resistant malaria parasites. L Delhas H Abessolo C Biot L Berry P Delcourt L Maciejewski J Brocard D Camus D Dive, Parasitol Res 2001 87 239 244 11293573 (Pubitemid 32208941)
5. In vitro antimalarial activity of a new organometallic analog, ferrocene-chloroquine. O Domarle G Blampain H Agnaniet T Nzadiyabi J Lebibi J Brocard L Maciejewski C Biot AJ Georges P Millet, Antimicrob Agents Chemother 1998 42 540 544 9517929 (Pubitemid 28114805)
6. In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum isolates from the Haut-Ogooue region of Gabon. C Atteke JM Ndong A Aubouy L Maciejewski J Brocard J Lebibi P Deloron, J Antimicrob Chemother 2003 51 1021 1024 10.1093/jac/dkg161 12654770 (Pubitemid 36503439)
7. Ferrocene-chloroquine analogues as antimalarial agents: in vitro activity of ferrochloroquine against 103 Gabonese isolates of Plasmodium falciparum. B Pradines T Fusai W Daries V Laloge C Rogier P Millet E Panconi M Kombila D Parzy, J Antimicrob Chemother 2001 48 179 184 10.1093/jac/48.2.179 11481286 (Pubitemid 32755277)
8. In vitro activities of ferrochloroquine against 55 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs. B Pradines A Tall C Rogier A Spiegel J Mosnier L Marrama T Fusai P Millet E Panconi JF Trape D Parzy, Trop Med Int Health 2002 7 265 270 10.1046/j.1365-3156.2002.00848.x 11903989 (Pubitemid 34264379)
9. Intermittent preventive treatment against malaria in infants in Gabon - a randomized, double-blind, placebo-controlled trial. MP Grobusch B Lell NG Schwarz J Gabor J Dörnemann M Pötschke S Oyakhirome GC Kiessling M Necek MU Langin PK Klouwenberg A Klopfer B Naumann H Altun ST Agnandji J Goesch M Decker CL Salazar C Supan DU Kombila L Borchert KB Koster P Pongratz AA Adegnika I Glasenapp S Issifou PG Kremsner, J Infect Dis 2007 196 1595 1602 10.1086/522160 18008242 (Pubitemid 351411956)
10. History and perspectives of medical research at the Albert Schweitzer Hospital in Lambaréné, Gabon. M Ramharter AA Adegnika ST Agnandji PB Matsiegui MP Grobusch S Winkler W Graninger J Krishna M Yazdanbakhsh B Mordmueller B Lell MA Missinou E Mavoungou S Issifou PG Kremsner, Wiener Klinische Wochenschrift/Middle European Journal of Medicine 2007 119 Suppl 3 8 12 10.1007/s00508-007-0857-5
11. High Prevalence of Asymptomatic Plasmodium falciparum Infection in Gabonese Adults. MP Dal-Bianco KB Köster UD Kombila JFK Kun MP Grobusch G Mombo-Ngoma PB Matsiegui C Supan CL Ospina Salazar MA Missinou S Issifou B Lell PG Kremsner, Am J Trop Med Hyg 2007 77 939 942 17984357 (Pubitemid 351837845)
12. Fosmidomycin-clindamycin for Plasmodium falciparum infections in African children. S Borrmann AA Adegnika PB Matsiegui S Issifou A Schindler DP Mawili-Mboumba T Baranek J Wiesner H Jomaa PG Kremsner, J Infect Dis 2004 189 901 908 10.1086/381785 14976608 (Pubitemid 38328192)
13. Studies on a new antimalarial compound: pyronaridine. C Chang T Lin-Hua C Jantanavivat, Trans R Soc Trop Med Hyg 1992 86 7 10 10.1016/0035-9203(92)90414- 8 1566313
14. Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers. F Mzayek H Deng FJ Mather EC Wasilevich H Liu CM Hadi DH Chansolme HA Murphy BH Melek AN Tenaglia DM Mushatt AW Dreisbach JJL Lertora DJ Krogstad, PLoS Clin Trials 2007 2 6.oi:10.1371/journal.pctr.0020006 10.1371/journal.pctr.0020006
15. Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria. S Oyakhirome S Issifou P Pongratz F Barondi M Ramharter JFK Kun MA Missinou B Lell PG Kremsner, Antimicrob Agents Chemother 2007 51 1869 1871 10.1128/AAC.01448-06 17325227 (Pubitemid 46744177)
16. In vitro activity of tafenoquine alone and in combination with artemisinin against Plasmodium falciparum. M Ramharter H Noedl K Thimasarn G Wiedermann G Wernsdorfer WH Wernsdorfer, Am J Trop Med Hyg 2002 67 39 43 12363062 (Pubitemid 35034318)
17. Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial. M Ramharter S Oyakhirome P Klein Klouwenberg AA Adégnika ST Agnandji MA Missinou PB Matsiégui B Mordmüller S Borrmann JFK Kun B Lell S Krishna W Graninger I Issifou PG Kremsner, Clin Infect Dis 2005 40 1777 1784 10.1086/430309 15909266 (Pubitemid 40799947)
18. Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon. M Ramharter F Kurth AC Schreier J Nemeth I Glasenapp S Bélard M Schlie J Kammer PK Koumba B Cisse B Mordmüller B Lell S Issifou C Oeuvray L Fleckenstein PG Kremsner, J Infect Dis 2008 198 911 919 10.1086/591096 18694333
19. Fosmidomycin for the treatment of malaria. J Wiesner S Borrmann H Jomaa, Parasitol Res 2003 90 Suppl 2 71 76 Review 10.1007/s00436-002-0770-9 12937969
20. Effectiveness of antimalarial drugs. JK Baird, N Engl J Med 2005 352 1565 1577 10.1056/NEJMra043207 15829537
21. Drugs for rheumatoid arthritis. Med Lett Drugs Ther 2000 42 57 64 10887424
22. Drugs for parasitic infections. Med Lett Drugs Ther 2004 46 1 12 14691408
23. Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria - A systematic review. HM McIntosh BM Greenwood, Ann Trop Med Parasitol 1998 93 265 270 (Pubitemid 28230515)
24. A systematic overview of published antimalarial drug trials. HY Mying P Tipmanee F Nosten NP Day S Pukrittayakamee S Looareesuwan NJ White, Trans R Soc Trop Med Hyg 2004 98 73 81 10.1016/S0035-9203(03)00014-2 14964805 (Pubitemid 38111554)
25. Antimalarial drug toxicity: A review. WRJ Taylor NJ White, Drug Safety 2004 27 25 61 10.2165/00002018-200427010-00003 14720085 (Pubitemid 38186936)
26. The treatment of malaria. NJ White, N Engl J Med 1996 335 800 806 10.1056/NEJM199609123351107 8703186 (Pubitemid 26296541)
27. Long-term effectiveness of antimalarial drugs in rheumatic diseases. JA Avina-Zubieta G Galindo-Rodriguez S Newman ME Suarez-Almazor AS Russell, Ann Rheum Dis 1998 57 583 587 10.1136/ard.57.10.582
28. Chloroquine blocks the background potassium current in guinea pig atrial myocytes. DE Benavides-Haro JA Sanchez-Chapula, Arch Pharmacol 2000 361 311 318 10.1007/s002109900185 (Pubitemid 30106344)
29. The pharmacokinetics and electrocardiographic effects of chloroquine in healthy subjects. MD Bustos F Gay B Diquet P Thomare D Warot, Trop Med Parasitol 1994 45 83 86 7939166 (Pubitemid 24209644)
30. Hypokalemia related to acute chloroquine ingestion. JL Clemessy C Favier SW Borron PE Hantson E Vicaut FJ Baud, Lancet 1995 346 877 880 10.1016/S0140-6736(95)92711-5 7564673
31. Treatment of severe chloroquine poisoning. B Riou P Barriot A Rimailho FJ Baud, N Engl J Med 1998 318 1 6 10.1056/NEJM198801073180101
32. Blockade of currents by antimalarial drug chloroquine in feline ventricular myocytes. JA Sanchez-Chapula E Salinas-Stefanon J Torres-Jacome DE Benavides-Haro RA Navarro-Polanco, J Pharmacol Exptl Therapeutics 2001 297 437 445 (Pubitemid 32242605)